2Liu PT, Stenger S. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science ,2006,311 : 1770-1773.
3DiCesar D J, Ploutz-Snyder R, Weinstock RS, et al. Vitamin D deficiency ismore common in type 2 than in type 1 diabetes. Diabetes Care, 2006, 29 : 174.
4Meyer MB, Goetsch PD, Pike JW. Genome-wide analysis of the VDR/ RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J Steroid Biochem Mol Bio1,2010,121 : 136-141.
5Buitrago C, Boland R. Caveolae and caveolin-1 are implicated in 1 alpha, 25 ( OH ) 2 -vitamin D3-dependent modulation of Src, MAPK cascades and ~DR localization in skeletal muscle cells. J Steroid Biochem Mol Biol, 2010,121 : 169-175.
6Brettschneider J, Hartmann N, Lehmensiek V, et al. Cerebrospinal fluid markers of idiopathic intracranial hypertension : Is the renin-angiotensino- gen system involved. Cephalalgia,2010,7:116-121.
7Deb DK, Sun T, Wong KE, et al. Combined vitamin D analog and AT1 re- ceptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int,2010,77:1000-1009.
8Martinesi M,Treves C, d' Albasio G, et al. Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononu- clear cells of inflammatory bowel disease patients. Inflamm Bowel Dis, 2008,14:597-604.
